Introduction {#sec1_1}
============

Acute gastrointestinal (GI) bleeding is a potentially lethal condition that usually leads to hospital admission. It is caused by peptic ulcers and esophageal or gastroduodenal erosions in almost 80% of patients \[[@B1]\]. Lower GI bleeding is diagnosed in 20--30% of all patients with GI bleeding \[[@B2]\]. The annual incidence of lower GI bleeding is approximately 0.03%, and it is associated with older age and preexisting comorbidities \[[@B2]\]. The Dieulafoy lesion was named after the French surgeon Georges Dieulafoy, who characterized it in 1898 \[[@B3]\]. Although Dieulafoy lesions are believed to account for only 1--2% of cases of acute GI bleeding, it is difficult to accurately determine their true incidence since they are nonsymptomatic until the commencement of bleeding and are too small to locate \[[@B1]\]. We herein describe the case of an 82-year-old man with a rectal Dieulafoy lesion who presented with active and persistent lower GI bleeding. The diagnosis was made based on multidetector-row computed tomography (MDCT), and endoscopic hemostasis was successfully achieved.

Case Report {#sec1_2}
===========

An 82-year-old male patient was referred to our hospital because of persistent hematochezia for approximately half a day. He had a history of atrial fibrillation, chronic heart failure, diabetes mellitus, and hyperuricemia. He had been receiving antiplatelet therapy for several years. He had no history of upper GI symptoms or nonsteroidal anti-inflammatory agent use. On arrival, his blood pressure was 118/56 mm Hg and his heart rate was 83 beats/min. Laboratory tests results revealed that the hemoglobin level was 8.3 g/dL (reference range 11.6--14.8 g/dL), the hematocrit level was 25.3% (reference range 35.1--44.4%), the platelet count was 11.7 × 10^4^/μL (reference range 15.8--34.8 × 10^4^/μL), and coagulation parameters were normal. His abdomen was soft and flat, without tenderness or rebound tenderness. Digital rectal examination revealed no mass, except for a dark-red blood clot and the presence of fresh blood. At the time, the source of bleeding was unknown. To identify the site of bleeding, prompt MDCT was performed, and the scan clearly showed active contrast extravasation in the lower rectum (Fig. [1](#F1){ref-type="fig"}). Subsequently, urgent colonoscopy was performed with bowel preparation, and pulsatile, fresh bleeding from the exposed nipple-like vessel was observed without mucosal defect or ulceration in the lower rectum (Fig. [2](#F2){ref-type="fig"}). The morphology of the lesion was consistent with a Dieulafoy lesion. Endoscopic hemostasis was achieved quickly using a pair of hemostatic forceps with soft coagulation at 60 W. The patient\'s systolic blood pressure decreased to 80 mm Hg during colonoscopy, and he needed blood transfusion. He received six units of red blood cells during his hospital stay.

After hemostasis had been achieved, the patient recovered and was discharged without recurrence of bleeding or other complications. He is doing well 6 months after hospital discharge.

Discussion {#sec1_3}
==========

Acute lower GI bleeding has an incidence of approximately 36 cases per 100,000 per year \[[@B4]\]. The most common causes are diverticular disease, colonic angiodysplasia, ischemic colitis, hemorrhoids, and colorectal polyps/neoplasms, accounting for more than 95% of cases \[[@B5]\]. The Dieulafoy lesion is a very rare cause of acute lower GI bleeding. It is characterized by a small mucosal defect in otherwise healthy mucosa containing a single protruding vessel, and it is most frequently observed in the stomach (70%), less commonly in the duodenum (15%), and rarely in the lower GI tract, including the rectum \[[@B3]\].

Although most patients with acute lower GI bleeding stop bleeding spontaneously and have favorable outcomes, morbidity and mortality are increased in older patients and those with comorbid medical conditions \[[@B6]\]. In most cases, the patients with a Dieulafoy lesion are aged and have multiple comorbidities, such as cardiopulmonary dysfunction and chronic renal insufficiency, with a history of recurrent use of nonsteroidal anti-inflammatory drugs (e.g., acetylsalicylic acid) and warfarin \[[@B7], [@B8]\]. These reported clinical characteristics of patients with a Dieulafoy lesion applied to our patient.

Colonoscopy is the gold standard in diagnosing acute lower GI bleeding \[[@B1], [@B2]\]. Estimates for the diagnostic yield in recent studies range from 42 to 100% \[[@B9]\]. The procedures include an epinephrine solution injection, thermal contact coagulation, argon plasma coagulation, hemostatic clips, and band ligation \[[@B2]\]. When endoscopy is used to successfully detect a Dieulafoy lesion, endoscopic treatment is achieved in 90% of patients with this lesion \[[@B10], [@B11]\]. However, the endoscopic procedure is not always successful, and repeat examinations are needed to make the diagnosis in some patients because the lesion is very small and blood, hematoma, or feces in the intestinal lumen prevent endoscopic visibility of the bleeding site. In such patients, there is a possibility that MDCT could be useful in the diagnosis \[[@B12], [@B13]\]. Computed tomography is noninvasive and can be used to detect active colonic hemorrhage at a lower rate (0.3 mL/min) compared with angiography (0.5 mL/min) \[[@B14]\]. In our patient, prompt MDCT enabled us to locate the bleeding site, and thus sequential endoscopic hemostasis was achieved quickly. Considering the outcome of our patient, we suggest MDCT as a useful tool to narrow down the location of lower GI bleeding.

In conclusion, detection of the bleeding site using MDCT followed by colonoscopic hemostasis is an efficient treatment strategy in patients with bleeding from a rectal Dieulafoy lesion. More studies are needed in the future to evaluate the potential use of such a strategy in the management of patients with lower GI bleeding.
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